In addition, stimulation of Nrf2/HO-1 antioxidant cascade mediated linagliptin’s antioxidant actions for combating the pathological manifestations of diabetic kidney disease [25] and inflammatory bowel disease [15]. This evidence concerns the gene HMOX1 and inflammatory bowel disease.